Mavrea Kalliopi, Efthymiou Vasiliki, Katsibardi Katerina, Tsarouhas Konstantinos, Kanaka-Gantenbein Christina, Spandidos Demetrios A, Chrousos George, Kattamis Antonis, Bacopoulou Flora
Clinic for Assessment of Adolescent Learning Difficulties, Center for Adolescent Medicine and UNESCO Chair on Adolescent Health Care, First Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens 11527, Greece.
University Research Institute of Maternal and Child Health and Precision Medicine, and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens 11527, Greece.
Oncol Lett. 2021 Apr;21(4):262. doi: 10.3892/ol.2021.12523. Epub 2021 Feb 5.
Pediatric cancer and its treatment may have an impact on the neurocognitive functions of childhood cancer survivors (CCS). The aim of the present meta-analysis was to compare the intelligence quotient (IQ) scores between CCS of acute lymphoblastic leukemia (ALL) and controls. A comprehensive electronic search identified original research articles that reported scores of the Wechsler Intelligence Scale (WISC; WISC-III, WISC-IV and WISC-R) for children and adolescents, aged 6-16 years at evaluation, survivors of ALL and healthy controls. The included CCS had completed anticancer treatment and were in remission at the time of assessment. A total of 16 studies were included in the meta-analysis, out of 128 extracted studies, and involved a total of 1,676 children and adolescents: 991 CCS (ALL) and 685 healthy controls. Among the studies, a random effects model revealed a moderate estimate of effect size [standardized mean difference (SMD), -0.78; 95% CI, -1.05 to -0.50], indicating that the WISC scores for total IQ were significantly lower in the CCS than in the controls. The mean total IQ range was 85.2-107.2 in the CCS and 88.4-114.1 in the controls. The difference in the mean total IQ between controls and CCS ranged from -13.8 to 20.6. As regards the WISC scores for verbal IQ, 11 studies were included. A random effects model revealed a moderate estimate of effect size (SMD, -0.71; 95% CI, -1.05 to -0.38), indicating that the WISC scores for verbal IQ were significantly lower in the CCS than in the controls. Among the 9 studies that had available data for performance IQ scores, a fixed effect model revealed a moderate estimate of effect size (SMD, -0.80; 95% CI, -1.09 to -0.52), indicating that the WISC scores for performance IQ were significantly lower in the CCS than in the controls. As the survival rates of children and adolescents with ALL are steadily increasing, regular, lifelong follow-up for neurocognitive late effects is imperative in order to improve their education and employment prospects and overall, their quality of life.
儿童癌症及其治疗可能会对儿童癌症幸存者(CCS)的神经认知功能产生影响。本荟萃分析的目的是比较急性淋巴细胞白血病(ALL)的CCS与对照组之间的智商(IQ)得分。全面的电子检索确定了原始研究文章,这些文章报告了6至16岁儿童和青少年在评估时的韦氏智力量表(WISC;WISC-III、WISC-IV和WISC-R)得分,ALL幸存者和健康对照组。纳入的CCS已完成抗癌治疗且在评估时处于缓解期。荟萃分析共纳入了128项提取研究中的16项研究,涉及总共1676名儿童和青少年:991名ALL的CCS和685名健康对照组。在这些研究中,随机效应模型显示效应大小的中度估计值[标准化均值差(SMD),-0.78;95%置信区间,-1.05至-0.50],表明ALL的CCS的总智商WISC得分显著低于对照组。CCS的平均总智商范围为85.2至107.2,对照组为88.4至114.1。对照组与ALL的CCS之间平均总智商的差异范围为-13.8至20.6。关于言语智商的WISC得分,纳入了11项研究。随机效应模型显示效应大小的中度估计值(SMD,-0.71;95%置信区间,-1.05至-0.38),表明ALL的CCS的言语智商WISC得分显著低于对照组。在有操作智商得分可用数据的9项研究中,固定效应模型显示效应大小的中度估计值(SMD,-0.80;95%置信区间,-1.09至-0.52),表明ALL的CCS的操作智商WISC得分显著低于对照组。由于ALL儿童和青少年的生存率在稳步提高,为了改善他们的教育和就业前景以及总体生活质量,对神经认知晚期效应进行定期的终身随访势在必行。